Treatment of Patients with Mild to Moderate Ulcerative Colitis: A Middle East Expert Consensus

被引：2

作者：

Al Awadhi, Sameer ^{[1
]}

Alboraie, Mohamed ^{[2
]}

Albaba, Emad Aldin ^{[3
]}

Almutairdi, Abdulelah ^{[4
]}

Alsaad, Monther ^{[5
]}

Azzam, Nahla ^{[6
]}

Barakat, Husam ^{[7
]}

D'Amico, Ferdinando ^{[8
,9
,10
]}

Danese, Silvio ^{[8
,9
]}

El Kady, Mohamed ^{[11
]}

Ghoneim, Hossam ^{[12
]}

Hamoudi, Waseem ^{[13
]}

Jazzar, Ahmad ^{[14
]}

Mosli, Mahmoud ^{[15
]}

Shehab, Hany ^{[16
]}

Sneineh, Awni Abu ^{[17
]}

机构：

[1] Rashid Hosp, Digest Dis Unit, Dubai 003206, U Arab Emirates

[2] Al Azhar Univ, Dept Internal Med, Cairo 11884, Egypt

[3] Almana Gen Hosp, Dept Med, Al Khobar 31952, Saudi Arabia

[4] King Faisal Specialist Hosp & Res Ctr, Dept Med, Riyadh 11564, Saudi Arabia

[5] Al Madar Med Ctr, POB 80789, Sharjah, U Arab Emirates

[6] King Saud Univ, Coll Med, Dept Med, Div Gastroenterol, Riyadh 11451, Saudi Arabia

[7] Yarmouk Univ, Dept Gastroenterol, Irbid 21163, Jordan

[8] IRCCS Osped San Raffaele, Gastroenterol & Endoscopy, I-20132 Milan, Italy

[9] Univ Vita Salute San Raffaele, I-20132 Milan, Italy

[10] Humanitas Univ, Dept Biomed Sci, I-20132 Milan, Italy

[11] Cairo Univ, Fac Med, Dept Med Pharmacol, Cairo 11559, Egypt

[12] Alexandria Univ, Med Res Inst, Immunol & Allergy Dept, Alexandria 5424041, Egypt

[13] Al Bashir Hosp, Internal Med Dept, Amman 11151, Jordan

[14] Sheikh Khalifa Med City, Gastroenterol Div, Abu Dhabi 51900, U Arab Emirates

[15] King Abdulaziz Univ Hosp, Dept Med, Jeddah 21589, Saudi Arabia

[16] Cairo Univ, Integrated Clin & Res Ctr Intestinal Disorders IC, Endem Med Dept, Gastroenterol Div, Cairo 3725121, Egypt

[17] Univ Jordan, Gastroenterol & Hepatol, Amman 11942, Jordan

来源：

JOURNAL OF CLINICAL MEDICINE | 2023年 / 12卷 / 21期

关键词：

5-ASA; mesalazine; budesonide MMX; ulcerative colitis; inflammatory bowel disease; RANDOMIZED CLINICAL-TRIAL; INFLAMMATORY-BOWEL-DISEASE; VS; 2.4; G/DAY; ORAL MESALAZINE; TOPICAL; 5-AMINOSALICYLATES; DOUBLE-BLIND; MAINTENANCE; REMISSION; EFFICACY; GUIDELINES;

D O I：

10.3390/jcm12216929

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The prevalence of ulcerative colitis (UC) in the Middle East is increasing, impacting the economic and healthcare burden. The management of patients with mild to moderate UC is still a challenge as several factors can affect optimal care, including drug choice, induction and maintenance dose, treatment optimization and de-escalation, therapy duration, monitoring, and safety profile. We conducted an expert consensus to standardize the management of patients with mild to moderate UC. Sixteen experts in inflammatory bowel diseases, through a well-established and accepted Delphi methodology, voted and approved eight statements in order to provide practical guidance to clinicians in the Middle East.

引用

页数：11

共 50 条

[31] Application of magnifying chromoscopy for the assessment of severity in patients with mild to moderate ulcerative colitis
Matsumoto, T
Kuroki, F
Mizuno, M
Nakamura, S
Iida, M
GASTROINTESTINAL ENDOSCOPY, 1997, 46 (05) : 400 - 405
[32] Rifaximin in patients with mild to moderate activity of ulcerative colitis: An open label study
Lukas, M
Konecny, M
Zboril, V
GASTROENTEROLOGY, 2002, 122 (04) : A434 - A434
[33] Drug Optimization in Patients with Mild-to-Moderate Ulcerative Colitis: A Global Survey
D'Amico, Ferdinando
Jairath, Vipul
Paridaens, Kristine
Peyrin-Biroulet, Laurent
Danese, Silvio
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (09)
[34] Unmet Medical Needs in Ulcerative Colitis: An Expert Group Consensus
Danese, Silvio
Allez, Matthieu
van Bodegraven, Ad A.
Dotan, Iris
Gisbert, Javier P.
Hart, Ailsa
Lakatos, Peter L.
Magro, Fernando
Peyrin-Biroulet, Laurent
Schreiber, Stefan
Tarabar, Dino
Vavricka, Stephan
Halfvarson, Jonas
Vermeire, Severine
DIGESTIVE DISEASES, 2019, 37 (04) : 266 - 283
[35] Pharmacy Budget Impact of Treatment Options in the Management of Mild-to-Moderate Ulcerative Colitis
Joshi, Ashish
Bazalo, Gary
Weiss, Richard
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S518 - S518
[36] Epidemiology, disease burden, and treatment challenges of ulcerative colitis in Africa and the Middle East
Sharara, Ala I.
Al Awadhi, Samir
Alharbi, Othman
Al Dhahab, Hisham
Mounir, Mohamed
Salese, Leonardo
Singh, Ena
Sunna, Nancy
Tarcha, Nadine
Mosli, Mahmoud
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 12 (09) : 883 - 897
[37] Patients' perceptions, attitudes, and experiences about the management of mild-to-moderate ulcerative colitis
Casellas, F.
Ginard, D.
Riestra, S.
Alfaro, N.
JOURNAL OF CROHNS & COLITIS, 2014, 8 : S134 - S135
[38] The Effect of Vitamin D on Serum Asymmetric Dimethylarginine in Patients with Mild to Moderate Ulcerative Colitis
Hosseinzadeh-Attar, Mohammad Javad
Sharifi, Amrollah
Nedjat, Saharnaz
Mohamadkhani, Ashraf
Vahedi, Homayoon
INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH, 2020, 90 (1-2) : 17 - 22
[39] Long-term clinical experience with Vedolizumab in patients with mild to moderate Ulcerative Colitis
Parikh, Asit
Leach, Timothy
Xu, Jing
Feagan, Brian
INFLAMMATORY BOWEL DISEASES, 2011, 17 : S23 - S23
[40] Long-Term Clinical Experience with Vedolizumab in Patients with Mild to Moderate Ulcerative Colitis
Parikh, Asit
Leach, Timothy
Xu, Jing
Feagan, Brian
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S467 - S467

← 1 2 3 4 5 →